| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.733 | 0.006 | 0.733 | Aldehyde oxidase inhibitor | 0.331 0.059 CID_154699764 | ||
| 0.551 | 0.016 | 0.551 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.348 0.154 CID_154699764 | ||
| 0.547 | 0.015 | 0.547 | GABA C receptor rho-3 antagonist | |||
| 0.518 | 0.024 | 0.518 | 5 Hydroxytryptamine release stimulant | |||
| 0.491 | 0.02 | 0.491 | MAP kinase kinase 6 inhibitor | 0.307 0.129 CID_154699764 | ||
| 0.453 | 0.013 | 0.453 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.24 0.116 CID_154699764 | ||
| 0.402 | 0.01 | 0.402 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.456 | 0.08 | 0.471 | Caspase 9 stimulant | 0.471 0.072 CID_154699764 | CID_154699764 | |
| 0.369 | 0.005 | 0.369 | Dopamine D4 antagonist | |||
| 0.37 | 0.007 | 0.37 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.364 | 0.01 | 0.364 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.359 | 0.006 | 0.359 | Toll-Like receptor 9 antagonist | |||
| 0.352 | 0.009 | 0.352 | 5 Hydroxytryptamine 2A antagonist | |||
| 0.377 | 0.034 | 0.377 | Calcium channel activator | 0.291 0.101 CID_154699764 | ||
| 0.356 | 0.014 | 0.356 | 5 Hydroxytryptamine antagonist | |||
| 0.359 | 0.024 | 0.588 | Cyclic AMP phosphodiesterase inhibitor | 0.588 0.004 CID_154699764 | CID_154699764 | |
| 0.324 | 0.004 | 0.324 | 5 Hydroxytryptamine 3 antagonist | |||
| 0.323 | 0.009 | 0.323 | Ribosomal protein S6 kinase inhibitor | 0.112 0.101 CID_154699764 | ||
| 0.322 | 0.008 | 0.322 | Alpha 2b adrenoreceptor antagonist | |||
| 0.321 | 0.008 | 0.321 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.311 | 0.003 | 0.311 | 5 Hydroxytryptamine 3B antagonist | |||
| 0.31 | 0.003 | 0.31 | 5 Hydroxytryptamine 3A agonist | |||
| 0.308 | 0.002 | 0.308 | Histamine H4 receptor antagonist | |||
| 0.31 | 0.006 | 0.31 | Alpha 2a adrenoreceptor antagonist | |||
| 0.308 | 0.005 | 0.308 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.305 | 0.005 | 0.305 | Protein kinase C zeta inhibitor | 0.117 0.034 CID_154699764 | ||
| 0.312 | 0.02 | 0.312 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.219 0.117 CID_154699764 | ||
| 0.319 | 0.028 | 0.319 | ErbB-1 antagonist | |||
| 0.295 | 0.004 | 0.295 | GABA receptor antagonist | |||
| 0.29 | 0.004 | 0.29 | GABA A receptor antagonist | |||
| 0.293 | 0.008 | 0.293 | Toll-Like receptor antagonist | |||
| 0.314 | 0.037 | 0.314 | Anticonvulsant | |||
| 0.31 | 0.04 | 0.386 | Psychostimulant | 0.386 0.025 CID_154699764 | CID_154699764 | |
| 0.272 | 0.008 | 0.272 | Check point kinase 2 inhibitor | |||
| 0.268 | 0.005 | 0.268 | Alpha 1 adrenoreceptor agonist | |||
| 0.266 | 0.006 | 0.266 | Protein kinase C mu inhibitor | 0.133 0.034 CID_154699764 | ||
| 0.277 | 0.017 | 0.277 | Alpha adrenoreceptor antagonist | |||
| 0.29 | 0.036 | 0.29 | MAP-kinase-activated kinase 5 inhibitor | |||
| 0.261 | 0.007 | 0.261 | Dopamine D1 antagonist | |||
| 0.296 | 0.044 | 0.296 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.257 | 0.01 | 0.257 | 5 Hydroxytryptamine agonist | |||
| 0.251 | 0.005 | 0.251 | Alpha adrenoreceptor agonist | |||
| 0.274 | 0.028 | 0.274 | LIM domain kinase 1 inhibitor | |||
| 0.256 | 0.012 | 0.256 | Alpha 1a adrenoreceptor antagonist | |||
| 0.258 | 0.014 | 0.258 | Alpha 1 adrenoreceptor antagonist | |||
| 0.247 | 0.003 | 0.247 | 5 Hydroxytryptamine 3 agonist | |||
| 0.249 | 0.009 | 0.249 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | |||
| 0.256 | 0.019 | 0.256 | Activin receptor-like kinase 2 inhibitor | |||
| 0.352 | 0.116 | 0.352 | Calcium channel L-type activator | 0.275 0.18 CID_154699764 | ||
| 0.34 | 0.105 | 0.407 | Histamine release inhibitor | 0.407 0.072 CID_154699764 | CID_154699764 | |
| 0.3 | 0.066 | 0.334 | Hypoxia-inducible factor 1 alpha inhibitor | 0.334 0.051 CID_154699764 | CID_154699764 | |
| 0.248 | 0.015 | 0.248 | Dopamine antagonist | |||
| 0.236 | 0.013 | 0.236 | Alpha 2 adrenoreceptor antagonist | |||
| 0.236 | 0.017 | 0.236 | Death-associated protein kinase 2 inhibitor | 0.146 0.115 CID_154699764 | ||
| 0.229 | 0.012 | 0.229 | Alpha 1b adrenoreceptor antagonist | |||
| 0.273 | 0.057 | 0.273 | HERG channel blocker | |||
| 0.252 | 0.037 | 0.252 | I kappa B kinase epsilon inhibitor | |||
| 0.262 | 0.049 | 0.262 | MAP kinase kinase 2 inhibitor | |||
| 0.215 | 0.008 | 0.215 | Platelet growth factor antagonist | |||
| 0.273 | 0.07 | 0.273 | Aryl hydrocarbon receptor agonist | |||
| 0.202 | 0.004 | 0.202 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.218 | 0.021 | 0.218 | Glutamate receptor antagonist | |||
| 0.242 | 0.046 | 0.242 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.2 | 0.004 | 0.2 | 5 Hydroxytryptamine 2 agonist | |||
| 0.191 | 0.004 | 0.191 | 5 Hydroxytryptamine 2A agonist | |||
| 0.203 | 0.017 | 0.203 | Dopamine D2 antagonist | |||
| 0.2 | 0.014 | 0.2 | Activin receptor-like kinase 4 inhibitor | |||
| 0.199 | 0.015 | 0.199 | Potassium channel (Ca-activated) activator | |||
| 0.187 | 0.003 | 0.187 | 5 Hydroxytryptamine 2B agonist | |||
| 0.238 | 0.055 | 0.238 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.187 | 0.005 | 0.187 | Benzodiazepine agonist | |||
| 0.185 | 0.004 | 0.185 | 5 Hydroxytryptamine 2C agonist | |||
| 0.24 | 0.062 | 0.24 | EphB2 antagonist | |||
| 0.202 | 0.024 | 0.202 | Platelet activating factor beta antagonist | |||
| 0.185 | 0.008 | 0.185 | Cyclin B3 inhibitor | |||
| 0.247 | 0.071 | 0.247 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.23 | 0.054 | 0.23 | CDC-like kinase 4 inhibitor | |||
| 0.24 | 0.071 | 0.24 | Potassium channel blocker | |||
| 0.181 | 0.013 | 0.181 | Death-associated protein kinase 1 inhibitor | |||
| 0.187 | 0.021 | 0.187 | GABA receptor agonist | |||
| 0.288 | 0.124 | 0.288 | Antiobesity | |||
| 0.179 | 0.015 | 0.179 | Hedgehog signaling inhibitor | |||
| 0.232 | 0.07 | 0.232 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.172 | 0.015 | 0.172 | ALK inhibitor | |||
| 0.166 | 0.01 | 0.166 | MAP-kinase-activated kinase inhibitor | |||
| 0.162 | 0.007 | 0.162 | Protein kinase B alpha inhibitor | |||
| 0.169 | 0.014 | 0.169 | Protein kinase C delta inhibitor | |||
| 0.172 | 0.019 | 0.172 | NMDA receptor antagonist | |||
| 0.189 | 0.036 | 0.189 | GABA C receptor rho-2 antagonist | |||
| 0.19 | 0.038 | 0.19 | NADPH oxidase inhibitor | |||
| 0.165 | 0.014 | 0.165 | Pim-3 kinase inhibitor | |||
| 0.216 | 0.066 | 0.216 | Death-associated protein kinase 3 inhibitor | |||
| 0.153 | 0.005 | 0.153 | Toll-Like receptor 7 antagonist | |||
| 0.208 | 0.06 | 0.208 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.151 | 0.004 | 0.151 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.17 | 0.025 | 0.17 | Alpha 2c adrenoreceptor antagonist | |||
| 0.191 | 0.047 | 0.191 | Acetylcholine M1 receptor antagonist | 0.157 0.068 CID_154699764 | ||
| 0.178 | 0.034 | 0.178 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.138 0.098 CID_154699764 | ||
| 0.153 | 0.01 | 0.153 | MAP-kinase-activated kinase 2 inhibitor | |||
| 0.148 | 0.006 | 0.148 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.155 | 0.014 | 0.155 | Alpha 1d adrenoreceptor antagonist | |||
| 0.165 | 0.024 | 0.165 | Protein kinase C gamma inhibitor | |||
| 0.155 | 0.015 | 0.155 | Protein kinase B gamma inhibitor | |||
| 0.201 | 0.061 | 0.201 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.209 | 0.07 | 0.209 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | |||
| 0.153 | 0.014 | 0.153 | Check point kinase 1 inhibitor | |||
| 0.183 | 0.047 | 0.183 | Neurotensin receptor agonist | |||
| 0.234 | 0.099 | 0.234 | Gastrin inhibitor | |||
| 0.16 | 0.024 | 0.16 | Pim-1 kinase inhibitor | |||
| 0.151 | 0.018 | 0.151 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.144 | 0.011 | 0.144 | Bromodomain-containing protein 2 inhibitor | |||
| 0.164 | 0.033 | 0.164 | Pregnane X receptor agonist | |||
| 0.2 | 0.069 | 0.2 | Focal adhesion kinase 2 inhibitor | |||
| 0.215 | 0.085 | 0.215 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.141 | 0.012 | 0.141 | Acetylcholine M4 receptor antagonist | |||
| 0.164 | 0.036 | 0.164 | Cyclin-dependent kinase 1 inhibitor | |||
| 0.179 | 0.052 | 0.179 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.16 | 0.033 | 0.16 | Antiadrenergic | |||
| 0.15 | 0.025 | 0.15 | Beta glucuronidase inhibitor | 0.147 0.026 CID_154699764 | ||
| 0.157 | 0.033 | 0.157 | Adrenaline antagonist | |||
| 0.142 | 0.018 | 0.142 | I kappa B kinase inhibitor | |||
| 0.164 | 0.041 | 0.164 | MAP3K9 inhibitor | 0.126 0.102 CID_154699764 | ||
| 0.139 | 0.017 | 0.139 | Dopamine D3 antagonist | |||
| 0.147 | 0.025 | 0.147 | Histamine H1 receptor antagonist | |||
| 0.131 | 0.009 | 0.131 | Pim-2 kinase inhibitor | |||
| 0.149 | 0.027 | 0.149 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.173 | 0.052 | 0.173 | Protein kinase (CK1) inhibitor | |||
| 0.125 | 0.005 | 0.125 | Phospholipase D inhibitor | |||
| 0.168 | 0.048 | 0.168 | Cyclin-dependent kinase 7 inhibitor | |||
| 0.144 | 0.024 | 0.144 | Phosphodiesterase 7B inhibitor | |||
| 0.141 | 0.024 | 0.141 | Acetylcholine M3 receptor agonist | |||
| 0.17 | 0.053 | 0.17 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.165 | 0.049 | 0.165 | Cyclin-dependent kinase inhibitor | |||
| 0.13 | 0.015 | 0.13 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.124 | 0.014 | 0.124 | Protein kinase B beta inhibitor | |||
| 0.223 | 0.113 | 0.223 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.125 | 0.015 | 0.125 | Protein kinase C alpha inhibitor | |||
| 0.288 | 0.179 | 0.288 | 5 Hydroxytryptamine release inhibitor | |||
| 0.192 | 0.084 | 0.192 | Clk dual-specificity kinase inhibitor | |||
| 0.124 | 0.016 | 0.124 | Glycine receptor antagonist | 0.083 0.051 CID_154699764 | ||
| 0.117 | 0.009 | 0.117 | NMDA receptor subunit 3B antagonist | |||
| 0.167 | 0.06 | 0.346 | Hexokinase inhibitor | 0.346 0.007 CID_154699764 | CID_154699764 | |
| 0.139 | 0.032 | 0.139 | Insulin receptor antagonist | |||
| 0.171 | 0.065 | 0.171 | Catenin beta inhibitor | |||
| 0.175 | 0.069 | 0.175 | Antipruritic | |||
| 0.192 | 0.087 | 0.192 | Platelet aggregation inhibitor | |||
| 0.108 | 0.004 | 0.108 | Potassium channel small-conductance Ca-activated activator | |||
| 0.113 | 0.011 | 0.113 | Alpha 2 adrenoreceptor agonist | |||
| 0.149 | 0.047 | 0.149 | Antibacterial (Helicobacter pylori) | |||
| 0.117 | 0.016 | 0.117 | I kappa B kinase 1 inhibitor | |||
| 0.161 | 0.06 | 0.161 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.141 | 0.041 | 0.141 | Interleukin 8 antagonist | |||
| 0.108 | 0.008 | 0.108 | MAP kinase kinase 7 inhibitor | |||
| 0.112 | 0.013 | 0.112 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.153 | 0.056 | 0.153 | MAP kinase kinase 4 inhibitor | |||
| 0.115 | 0.02 | 0.115 | Cyclin-dependent kinase 4 inhibitor | |||
| 0.206 | 0.111 | 0.206 | Superoxide dismutase inhibitor | |||
| 0.108 | 0.014 | 0.108 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.102 | 0.009 | 0.102 | Histamine agonist | |||
| 0.109 | 0.015 | 0.109 | Acetylcholine M5 receptor agonist | |||
| 0.101 | 0.008 | 0.101 | Glucosylceramidase inhibitor | 0.091 0.011 CID_154699764 | ||
| 0.118 | 0.026 | 0.118 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.132 | 0.041 | 0.132 | Transcription factor STAT6 inhibitor | 0.103 0.099 CID_154699764 | ||
| 0.122 | 0.033 | 0.122 | Protein kinase A inhibitor | |||
| 0.156 | 0.067 | 0.156 | Protein kinase C nu inhibitor | |||
| 0.096 | 0.008 | 0.096 | MDM2 inhibitor | |||
| 0.096 | 0.008 | 0.096 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.138 | 0.051 | 0.138 | MAP kinase 12 inhibitor | |||
| 0.105 | 0.021 | 0.105 | CDC7 inhibitor | |||
| 0.087 | 0.003 | 0.087 | Histamine H4 receptor agonist | |||
| 0.116 | 0.033 | 0.116 | Histamine N-methyltransferase inhibitor | 0.09 0.056 CID_154699764 | ||
| 0.163 | 0.081 | 0.163 | ATPase inhibitor | 0.134 0.133 CID_154699764 | ||
| 0.114 | 0.032 | 0.114 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.147 | 0.065 | 0.147 | Tyrosine-protein kinase receptor antagonist | |||
| 0.163 | 0.082 | 0.163 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.09 | 0.013 | 0.09 | Potassium channel (Ca-activated) blocker | |||
| 0.138 | 0.061 | 0.138 | Protein kinase (CK1) delta inhibitor | |||
| 0.092 | 0.016 | 0.092 | I kappa B kinase 2 inhibitor | |||
| 0.094 | 0.019 | 0.094 | Acetylcholine M5 receptor antagonist | |||
| 0.089 | 0.013 | 0.089 | Toll-Like receptor 8 antagonist | |||
| 0.113 | 0.038 | 0.113 | Insulin growth factor antagonist | |||
| 0.143 | 0.069 | 0.143 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.102 | 0.03 | 0.102 | Phosphodiesterase 11A inhibitor | |||
| 0.102 | 0.03 | 0.102 | Phosphodiesterase XI inhibitor | |||
| 0.124 | 0.052 | 0.124 | MAP kinase 13 inhibitor | |||
| 0.075 | 0.004 | 0.075 | Histamine H1 receptor agonist | |||
| 0.076 | 0.007 | 0.076 | GABA B receptor antagonist | |||
| 0.086 | 0.017 | 0.086 | Cyclin B1 inhibitor | |||
| 0.11 | 0.042 | 0.11 | mTOR complex 1 inhibitor | |||
| 0.106 | 0.038 | 0.106 | Insulin like growth factor 1 antagonist | |||
| 0.114 | 0.046 | 0.114 | GABA C receptor rho-1 antagonist | |||
| 0.099 | 0.032 | 0.099 | NMDA 2 receptor antagonist | |||
| 0.087 | 0.022 | 0.087 | Protein kinase C beta inhibitor | 0.068 0.051 CID_154699764 | ||
| 0.145 | 0.081 | 0.145 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.106 | 0.043 | 0.106 | Acetylcholine agonist | |||
| 0.085 | 0.022 | 0.085 | NMDA 2C receptor antagonist | |||
| 0.114 | 0.051 | 0.114 | Urease inhibitor | |||
| 0.068 | 0.005 | 0.068 | Alpha 1L adrenoreceptor agonist | |||
| 0.133 | 0.072 | 0.133 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.17 | 0.11 | 0.17 | Neurotrophic factor enhancer | |||
| 0.076 | 0.017 | 0.076 | Cyclin B2 inhibitor | |||
| 0.083 | 0.024 | 0.083 | Protein kinase C iota inhibitor | |||
| 0.076 | 0.018 | 0.076 | Cyclin B inhibitor | |||
| 0.122 | 0.063 | 0.122 | Aurora-B kinase inhibitor | |||
| 0.193 | 0.134 | 0.391 | DNA synthesis inhibitor | 0.391 0.023 CID_154699764 | CID_154699764 | |
| 0.072 | 0.014 | 0.072 | NMDA receptor subunit 3A antagonist | |||
| 0.124 | 0.066 | 0.124 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.111 | 0.052 | 0.111 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.098 | 0.04 | 0.098 | GABA A receptor agonist | |||
| 0.141 | 0.083 | 0.141 | MAP kinase 3 inhibitor | |||
| 0.085 | 0.028 | 0.085 | 5 Hydroxytryptamine 1D antagonist | |||
| 0.065 | 0.008 | 0.065 | Vascular adhesion protein 1 inhibitor | |||
| 0.095 | 0.039 | 0.095 | mTOR complex 2 inhibitor | |||
| 0.172 | 0.116 | 0.172 | Dyrk kinase inhibitor | |||
| 0.12 | 0.063 | 0.12 | Platelet activating factor antagonist | |||
| 0.129 | 0.073 | 0.129 | RET inhibitor | |||
| 0.183 | 0.127 | 0.309 | RNA-directed DNA polymerase inhibitor | 0.309 0.03 CID_154699764 | CID_154699764 | |
| 0.105 | 0.05 | 0.105 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.111 | 0.057 | 0.402 | AMP-activated protein kinase stimulant | 0.402 0.004 CID_154699764 | CID_154699764 | |
| 0.105 | 0.051 | 0.105 | Antihistaminic | |||
| 0.132 | 0.079 | 0.132 | Aurora-C kinase inhibitor | |||
| 0.061 | 0.008 | 0.061 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.077 | 0.025 | 0.077 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.114 | 0.062 | 0.114 | Polo-like kinase-4 inhibitor | |||
| 0.065 | 0.015 | 0.065 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.164 | 0.113 | 0.164 | Growth factor agonist | |||
| 0.09 | 0.04 | 0.09 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.062 | 0.012 | 0.062 | Benzodiazepine antagonist | |||
| 0.061 | 0.011 | 0.061 | Kainate receptor 2 antagonist | |||
| 0.089 | 0.04 | 0.089 | Transforming growth factor beta 3 antagonist | |||
| 0.059 | 0.009 | 0.059 | Acetylcholine M4 receptor agonist | |||
| 0.071 | 0.022 | 0.071 | Dopamine D4 agonist | |||
| 0.136 | 0.088 | 0.136 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | |||
| 0.141 | 0.094 | 0.141 | Polo-like kinase-3 inhibitor | |||
| 0.144 | 0.097 | 0.144 | CDC-like kinase 2 inhibitor | |||
| 0.089 | 0.042 | 0.089 | Janus tyrosine kinase 2 inhibitor | |||
| 0.057 | 0.011 | 0.057 | Acid-sensing ion channel blocker | |||
| 0.067 | 0.022 | 0.067 | AMPA receptor antagonist | |||
| 0.131 | 0.086 | 0.131 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.144 | 0.1 | 0.144 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | |||
| 0.095 | 0.051 | 0.095 | Histamine antagonist | |||
| 0.071 | 0.027 | 0.071 | Cyclin D1 inhibitor | |||
| 0.108 | 0.065 | 0.108 | Multidrug resistance-associated protein 1 inhibitor | 0.102 0.074 CID_154699764 | ||
| 0.179 | 0.135 | 0.179 | DNA damaging | |||
| 0.075 | 0.032 | 0.075 | Aryl hydrocarbon receptor antagonist | |||
| 0.115 | 0.073 | 0.115 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | |||
| 0.115 | 0.073 | 0.115 | Abl kinase inhibitor | |||
| 0.108 | 0.066 | 0.108 | GABA C receptor antagonist | |||
| 0.118 | 0.076 | 0.195 | DNA repair enzyme inhibitor | 0.195 0.009 CID_154699764 | CID_154699764 | |
| 0.138 | 0.096 | 0.138 | Tyrosine kinase inhibitor | |||
| 0.057 | 0.017 | 0.057 | Purinergic P2X4 antagonist | |||
| 0.063 | 0.024 | 0.063 | Transforming growth factor beta 1 antagonist | |||
| 0.098 | 0.059 | 0.098 | Fibroblast growth factor 1 antagonist | |||
| 0.088 | 0.049 | 0.088 | Neuropeptide Y antagonist | |||
| 0.046 | 0.008 | 0.046 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.053 | 0.016 | 0.053 | Poly(ADP-ribose) polymerase 1 inhibitor | |||
| 0.102 | 0.065 | 0.102 | Aurora-A kinase inhibitor | |||
| 0.075 | 0.039 | 0.075 | Tyk2 inhibitor | |||
| 0.159 | 0.123 | 0.159 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.065 | 0.03 | 0.065 | Acetylcholine muscarinic agonist | |||
| 0.118 | 0.084 | 0.118 | Phosphodiesterase inhibitor | |||
| 0.062 | 0.029 | 0.062 | 5 Hydroxytryptamine 7 agonist | |||
| 0.121 | 0.089 | 0.121 | Protein kinase (CK1) gamma inhibitor | |||
| 0.068 | 0.036 | 0.068 | Cannabinoid CB1 receptor antagonist | |||
| 0.063 | 0.032 | 0.063 | Protein kinase C theta inhibitor | |||
| 0.042 | 0.011 | 0.042 | Poly(ADP-ribose) polymerase 2 inhibitor | |||
| 0.053 | 0.023 | 0.053 | Dopamine D5 antagonist | |||
| 0.089 | 0.06 | 0.089 | CDK/cyclin complex inhibitor | |||
| 0.096 | 0.067 | 0.096 | Protein kinase (CK2) inhibitor | |||
| 0.037 | 0.009 | 0.037 | 5 Hydroxytryptamine 6 agonist | |||
| 0.062 | 0.034 | 0.062 | Cyclin A1 inhibitor | |||
| 0.066 | 0.038 | 0.066 | Adrenaline uptake inhibitor | |||
| 0.068 | 0.04 | 0.068 | 5 Hydroxytryptamine uptake inhibitor | |||
| 0.033 | 0.006 | 0.033 | Imidazoline I1 receptor antagonist | |||
| 0.135 | 0.108 | 0.135 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.107 | 0.081 | 0.107 | TRKA antagonist | |||
| 0.062 | 0.037 | 0.062 | CDK4/cyclin D1 inhibitor | |||
| 0.126 | 0.102 | 0.224 | Insulin secretagoues | 0.224 0.026 CID_154699764 | CID_154699764 | |
| 0.045 | 0.021 | 0.045 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.104 | 0.08 | 0.104 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.086 | 0.063 | 0.292 | NADH dehydrogenase inhibitor | 0.292 0.007 CID_154699764 | CID_154699764 | |
| 0.034 | 0.011 | 0.034 | Kainate receptor 4 antagonist | |||
| 0.046 | 0.023 | 0.046 | Cyclin D3 inhibitor | |||
| 0.049 | 0.026 | 0.049 | Acetylcholine M1 receptor agonist | |||
| 0.141 | 0.12 | 0.141 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.049 | 0.028 | 0.049 | CC chemokine 4 receptor antagonist | |||
| 0.053 | 0.033 | 0.053 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.098 | 0.077 | 0.098 | EphA2 antagonist | |||
| 0.071 | 0.051 | 0.071 | Phosphodiesterase V inhibitor | |||
| 0.041 | 0.021 | 0.041 | Somatostatin 4 agonist | |||
| 0.056 | 0.037 | 0.056 | Protein kinase C eta inhibitor | |||
| 0.045 | 0.026 | 0.045 | Nerve growth factor antagonist | |||
| 0.089 | 0.072 | 0.089 | Alpha 2d adrenoreceptor antagonist | |||
| 0.107 | 0.09 | 0.107 | Nav1.3 sodium channel blocker | |||
| 0.043 | 0.026 | 0.043 | Kainate receptor antagonist | |||
| 0.136 | 0.119 | 0.136 | Tumour necrosis factor antagonist | |||
| 0.034 | 0.018 | 0.034 | AMPA 1 receptor antagonist | |||
| 0.05 | 0.034 | 0.05 | Potassium channel (Inward rectifier) blocker | |||
| 0.046 | 0.03 | 0.046 | Phosphodiesterase X inhibitor | |||
| 0.046 | 0.03 | 0.046 | Phosphodiesterase 10A inhibitor | |||
| 0.039 | 0.024 | 0.039 | DNA gyrase subunit B inhibitor | |||
| 0.062 | 0.046 | 0.062 | DNA gyrase inhibitor | |||
| 0.035 | 0.019 | 0.035 | ATR kinase inhibitor | |||
| 0.035 | 0.021 | 0.035 | Benzodiazepine receptor peripheral-type antagonist | |||
| 0.057 | 0.043 | 0.057 | CDK4/cyclin D inhibitor | |||
| 0.079 | 0.065 | 0.079 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.039 | 0.028 | 0.039 | AMPA 4 receptor antagonist | |||
| 0.066 | 0.055 | 0.066 | Phosphodiesterase 5A inhibitor | |||
| 0.089 | 0.078 | 0.089 | Phosphodiesterase 6D inhibitor | 0.089 0.079 CID_154699764 | ||
| 0.024 | 0.013 | 0.024 | Bombesin agonist | |||
| 0.051 | 0.041 | 0.051 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.057 | 0.048 | 0.057 | Phosphodiesterase 1A inhibitor | |||
| 0.065 | 0.056 | 0.065 | Transforming growth factor antagonist | |||
| 0.068 | 0.059 | 0.068 | Rho-associated kinase I inhibitor | |||
| 0.111 | 0.103 | 0.111 | Interleukin 1 antagonist | |||
| 0.048 | 0.04 | 0.048 | Alpha 1b adrenoreceptor agonist | |||
| 0.019 | 0.011 | 0.019 | Alpha 2a adrenoreceptor agonist | |||
| 0.046 | 0.038 | 0.046 | Chemokine receptor agonist | |||
| 0.029 | 0.021 | 0.029 | AMPA 3 receptor antagonist | |||
| 0.072 | 0.066 | 0.072 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.024 | 0.018 | 0.024 | NMDA receptor glycine site antagonist | |||
| 0.02 | 0.015 | 0.02 | Kainate receptor 5 antagonist | |||
| 0.093 | 0.087 | 0.093 | Glycogen synthase kinase-3 beta inhibitor | |||
| 0.056 | 0.05 | 0.056 | NMDA receptor glycine site agonist | |||
| 0.019 | 0.013 | 0.019 | Bombesin 3 receptor agonist | |||
| 0.047 | 0.042 | 0.047 | mTOR inhibitor | |||
| 0.063 | 0.058 | 0.063 | Cannabinoid receptor antagonist | |||
| 0.064 | 0.059 | 0.064 | Telomerase inhibitor | |||
| 0.041 | 0.036 | 0.041 | 5 Hydroxytryptamine 1A agonist | |||
| 0.115 | 0.11 | 0.115 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.045 | 0.041 | 0.045 | Bromodomain-containing protein 3 inhibitor | |||
| 0.116 | 0.112 | 0.116 | Src kinase inhibitor | |||
| 0.029 | 0.025 | 0.029 | LIM domain kinase 2 inhibitor | |||
| 0.02 | 0.016 | 0.02 | Kainate receptor 1 antagonist | |||
| 0.089 | 0.086 | 0.089 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.019 | 0.017 | 0.038 | Adenosine kinase inhibitor | 0.038 0.008 CID_154699764 | CID_154699764 | |
| 0.065 | 0.063 | 0.065 | Nav1.8 sodium channel blocker | |||
| 0.009 | 0.008 | 0.009 | CXC chemokine 3 receptor agonist | |||
| 0.015 | 0.014 | 0.015 | Nicotinic alpha4 receptor agonist | |||
| 0.044 | 0.042 | 0.044 | Adenosine A2b receptor antagonist | |||
| 0.049 | 0.047 | 0.049 | Myc inhibitor | |||
| 0.031 | 0.03 | 0.031 | CDK6/cyclin D3 inhibitor | |||
| 0.083 | 0.082 | 0.083 | Glutamate release inhibitor | |||
| 0.088 | 0.089 | 0.102 | DNA intercalator | 0.102 0.071 CID_154699764 | CID_154699764 | |
| 0.066 | 0.067 | 0.154 | Adenosine A3 receptor antagonist | 0.154 0.012 CID_154699764 | CID_154699764 | |
| 0.027 | 0.038 | 0.105 | Phosphoglycerate kinase inhibitor | 0.105 0.006 CID_154699764 | CID_154699764 | |
| 0.072 | 0.1 | 0.276 | Topoisomerase I inhibitor | 0.276 0.013 CID_154699764 | CID_154699764 | |
| 0.038 | 0.068 | 0.062 | Factor IXa inhibitor | 0.062 0.025 CID_154699764 | CID_154699764 | |
| 0.033 | 0.073 | 0.205 | Adenosine A1 receptor antagonist | 0.205 0.011 CID_154699764 | CID_154699764 | |
| 0.036 | 0.094 | 0.055 | Adenosine A2 receptor antagonist | 0.055 0.054 CID_154699764 | CID_154699764 | |
| 0.102 | 0.164 | 0.126 | Hemostatic | 0.126 0.102 CID_154699764 | CID_154699764 | |
| 0.119 | 0.188 | 0.15 | Phospholipase C inhibitor | 0.15 0.107 CID_154699764 | CID_154699764 | |
| 0.029 | 0.099 | 0.06 | Adenosine A2a receptor antagonist | 0.06 0.045 CID_154699764 | CID_154699764 | |
| 0.119 | 0.193 | 0.174 | Heat shock protein 70 antagonist | 0.174 0.015 CID_154699764 | CID_154699764 | |
| 0.063 | 0.137 | 0.101 | DNA directed RNA polymerase inhibitor | 0.101 0.056 CID_154699764 | CID_154699764 | |
| 0.064 | 0.146 | 0.194 | Adenylate cyclase inhibitor | 0.194 0.027 CID_154699764 | CID_154699764 | |
| 0.017 | 0.1 | 0.099 | Purinergic P2Y antagonist | 0.099 0.009 CID_154699764 | CID_154699764 | |
| 0.032 | 0.117 | 0.061 | Heparanase inhibitor | 0.061 0.021 CID_154699764 | CID_154699764 | |
| 0.056 | 0.144 | 0.166 | Aminoacyl-tRNA synthetase inhibitor | 0.166 0.015 CID_154699764 | CID_154699764 | |
| 0.15 | 0.24 | 0.385 | Vasodilator, coronary | 0.385 0.04 CID_154699764 | CID_154699764 | |
| 0.018 | 0.114 | 0.05 | Guanylate cyclase inhibitor | 0.05 0.021 CID_154699764 | CID_154699764 | |
| 0.028 | 0.129 | 0.063 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.063 0.031 CID_154699764 | CID_154699764 | |
| 0.145 | 0.251 | 0.23 | Vasodilator, peripheral | 0.23 0.144 CID_154699764 | CID_154699764 | |
| 0.016 | 0.128 | 0.114 | Phosphorylase inhibitor | 0.114 0.011 CID_154699764 | CID_154699764 | |
| 0.052 | 0.175 | 0.155 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.155 0.025 CID_154699764 | CID_154699764 | |
| 0.057 | 0.181 | 0.146 | Amylase inhibitor | 0.146 0.066 CID_154699764 | CID_154699764 | |
| 0.092 | 0.247 | 0.22 | Spasmolytic | 0.22 0.106 CID_154699764 | CID_154699764 | |
| 0.006 | 0.162 | 0.021 | Purinergic P2Y12 antagonist | 0.021 0.017 CID_154699764 | CID_154699764 | |
| 0.082 | 0.243 | 0.238 | Interleukin agonist | 0.238 0.088 CID_154699764 | CID_154699764 | |
| 0.141 | 0.303 | 0.192 | Caspase 3 stimulant | 0.192 0.182 CID_154699764 | CID_154699764 | |
| 0.029 | 0.202 | 0.075 | Purinergic P2X1 antagonist | 0.075 0.028 CID_154699764 | CID_154699764 | |
| 0.018 | 0.212 | 0.064 | Biliverdin reductase inhibitor | 0.064 0.037 CID_154699764 | CID_154699764 | |
| 0.074 | 0.271 | 0.326 | DNA methylase inhibitor | 0.326 0.021 CID_154699764 | CID_154699764 | |
| 0.068 | 0.276 | 0.288 | DNA methyltransferase I inhibitor | 0.288 0.031 CID_154699764 | CID_154699764 | |
| 0.07 | 0.281 | 0.283 | Platelet adhesion inhibitor | 0.283 0.039 CID_154699764 | CID_154699764 | |
| 0.054 | 0.27 | 0.125 | Adenylate kinase inhibitor | 0.125 0.04 CID_154699764 | CID_154699764 | |
| 0.037 | 0.253 | 0.115 | Antineoplastic alkaloid | 0.115 0.04 CID_154699764 | CID_154699764 | |
| 0.046 | 0.268 | 0.211 | Cytidine deaminase inhibitor | 0.211 0.042 CID_154699764 | CID_154699764 | |
| 0.051 | 0.279 | 0.102 | Aldehyde dehydrogenase inhibitor | 0.102 0.095 CID_154699764 | CID_154699764 | |
| 0.035 | 0.272 | 0.152 | UDP-glucose 4-epimerase inhibitor | 0.152 0.028 CID_154699764 | CID_154699764 | |
| 0.101 | 0.355 | 0.325 | Immunomodulator | 0.325 0.069 CID_154699764 | CID_154699764 | |
| 0.109 | 0.378 | 0.414 | Antibacterial | 0.414 0.07 CID_154699764 | CID_154699764 | |
| 0.091 | 0.366 | 0.217 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.217 0.06 CID_154699764 | CID_154699764 | |
| 0.061 | 0.345 | 0.122 | NOS3 expression enhancer | 0.122 0.111 CID_154699764 | CID_154699764 | |
| 0.086 | 0.376 | 0.274 | Cholesterol antagonist | 0.274 0.108 CID_154699764 | CID_154699764 | |
| 0.073 | 0.377 | 0.271 | Transcription factor NF kappa B inhibitor | 0.271 0.113 CID_154699764 | CID_154699764 | |
| 0.046 | 0.365 | 0.333 | Immunostimulant | 0.333 0.069 CID_154699764 | CID_154699764 | |
| 0.005 | 0.327 | 0.019 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.019 0.007 CID_154699764 | CID_154699764 | |
| 0.074 | 0.424 | 0.265 | Antithrombotic | 0.265 0.115 CID_154699764 | CID_154699764 | |
| 0.009 | 0.366 | 0.059 | Phosphofructokinase-1 inhibitor | 0.059 0.058 CID_154699764 | CID_154699764 | |
| 0.09 | 0.461 | 0.239 | Apoptosis antagonist | 0.239 0.138 CID_154699764 | CID_154699764 | |
| 0.039 | 0.419 | 0.283 | Platelet antagonist | 0.283 0.059 CID_154699764 | CID_154699764 | |
| 0.042 | 0.45 | 0.312 | Vasodilator | 0.312 0.044 CID_154699764 | CID_154699764 | |
| 0.082 | 0.504 | 0.124 | CC chemokine 6 receptor antagonist | 0.124 0.098 CID_154699764 | CID_154699764 | |
| 0.011 | 0.433 | 0.036 | Purinergic P2Y2 antagonist | 0.036 0.02 CID_154699764 | CID_154699764 | |
| 0.083 | 0.524 | 0.39 | Apoptosis agonist | 0.39 0.118 CID_154699764 | CID_154699764 | |
| 0.072 | 0.559 | 0.306 | Cyclophilin D inhibitor | 0.306 0.157 CID_154699764 | CID_154699764 | |
| 0.005 | 0.492 | 0.017 | Adenosine A2b receptor agonist | 0.017 0.008 CID_154699764 | CID_154699764 | |
| 0.026 | 0.519 | 0.178 | Free radical scavenger | 0.178 0.116 CID_154699764 | CID_154699764 | |
| 0.079 | 0.589 | 0.309 | Antiinflammatory | 0.309 0.207 CID_154699764 | CID_154699764 | |
| 0.004 | 0.519 | 0.02 | Adenosine A3 receptor agonist | 0.02 0.008 CID_154699764 | CID_154699764 | |
| 0.003 | 0.605 | 0.039 | Adenosine A1 receptor agonist | 0.039 0.008 CID_154699764 | CID_154699764 | |
| 0.019 | 0.621 | 0.065 | Adenine nucleotide translocase inhibitor | 0.065 0.021 CID_154699764 | CID_154699764 | |
| 0.005 | 0.625 | 0.062 | Selectin antagonist | 0.062 0.048 CID_154699764 | CID_154699764 | |
| 0.003 | 0.646 | 0.029 | Purinergic P2X agonist | 0.029 0.018 CID_154699764 | CID_154699764 | |
| 0.033 | 0.677 | 0.219 | Hypoglycemic | 0.219 0.097 CID_154699764 | CID_154699764 | |
| 0.062 | 0.725 | 0.225 | Interleukin 2 agonist | 0.225 0.149 CID_154699764 | CID_154699764 | |
| 0.013 | 0.708 | 0.17 | Antioxidant | 0.17 0.142 CID_154699764 | CID_154699764 | |
| 0.003 | 0.719 | 0.019 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.019 0.015 CID_154699764 | CID_154699764 | |
| 0.019 | 0.759 | 0.263 | Immunosuppressant | 0.263 0.139 CID_154699764 | CID_154699764 | |
| 0.001 | 0.766 | 0.011 | Purinergic P2Y agonist | 0.011 0.01 CID_154699764 | CID_154699764 | |
| 0.001 | 0.777 | 0.015 | Purinergic P2 agonist | 0.015 0.01 CID_154699764 | CID_154699764 | |
| 0.001 | 0.777 | 0.015 | Purinergic receptor agonist | 0.015 0.01 CID_154699764 | CID_154699764 | |
| 0.006 | 0.794 | 0.085 | Uric acid excretion stimulant | 0.085 0.074 CID_154699764 | CID_154699764 | |
| 0.01 | 0.802 | 0.27 | Angiogenesis stimulant | 0.27 0.061 CID_154699764 | CID_154699764 | |
| 0.016 | 0.811 | 0.182 | DNA polymerase I inhibitor | 0.182 0.034 CID_154699764 | CID_154699764 | |
| 0.006 | 0.805 | 0.053 | Protein 50S ribosomal subunit inhibitor | 0.053 0.037 CID_154699764 | CID_154699764 | |
| 0.056 | 0.855 | 0.326 | Peptidyltransferase inhibitor | 0.326 0.017 CID_154699764 | CID_154699764 | |
| 0.019 | 0.857 | 0.173 | Hepatoprotectant | 0.173 0.087 CID_154699764 | CID_154699764 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |